Matching the nano- to the meso-scale: measuring deposit–surface interactions with atomic force microscopy and micromanipulation

Many researchers have studied the effects of changing the surface on fouling and cleaning. In biofouling the 'Baier curve' is a well-known result which relates adhesion to surface energy, and papers on the effect of changing surface energy to food fouling can be found more than 40 years ago. Recently the use of modified surfaces, at least at a research level, has been widespread. Here two different ways of studying surface-deposit interactions have been compared. Atomic force microscopy (AFM) is a method for probing interactions at a molecular level, and can measure (for example) the interaction between substrate and surfaces at a nm-scale. At a μm-mm level, we have developed a micromanipulation tool that can measure the force required to remove the deposit; the measure incorporates both surface and bulk deformation effects. The two methods have been compared by studying a range of model soils: toothpaste, as an example of a soil that can be removed by fluid flow alone, and confectionery soils. Removal has been studied from glass, stainless steel and fluorinated surfaces as examples of the sort of surfaces that can be found in practice. AFM measurements were made by using functionalized tips in force mode. The two types of probe give similar results, although the rheology of the soil affects the measurement from the micromanipulation probe under some circumstances. The data suggests that either method could be used to test candidate surfaces

Characteristics of Early-Onset vs Late-Onset Colorectal Cancer: A Review.

The incidence of early-onset colorectal cancer (younger than 50 years) is rising globally, the reasons for which are unclear. It appears to represent a unique disease process with different clinical, pathological, and molecular characteristics compared with late-onset colorectal cancer. Data on oncological outcomes are limited, and sensitivity to conventional neoadjuvant and adjuvant therapy regimens appear to be unknown. The purpose of this review is to summarize the available literature on early-onset colorectal cancer. Within the next decade, it is estimated that 1 in 10 colon cancers and 1 in 4 rectal cancers will be diagnosed in adults younger than 50 years. Potential risk factors include a Westernized diet, obesity, antibiotic usage, and alterations in the gut microbiome. Although genetic predisposition plays a role, most cases are sporadic. The full spectrum of germline and somatic sequence variations implicated remains unknown. Younger patients typically present with descending colonic or rectal cancer, advanced disease stage, and unfavorable histopathological features. Despite being more likely to receive neoadjuvant and adjuvant therapy, patients with early-onset disease demonstrate comparable oncological outcomes with their older counterparts. The clinicopathological features, underlying molecular profiles, and drivers of early-onset colorectal cancer differ from those of late-onset disease. Standardized, age-specific preventive, screening, diagnostic, and therapeutic strategies are required to optimize outcomes

VO2/DO2 relationship: How to get rid of methodological pitfalls?

SCOPUS: re.jinfo:eu-repo/semantics/publishe